Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
500 participants
OBSERVATIONAL
2015-06-01
2020-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to assess frailty according to different frailty tools among KT candidates and to establish potential biomarkers of frailty.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Systemic Activation of Inflammasomes and Frailty in Older Candidates to Kidney Transplantation
NCT06887075
Chronic Kidney Disease Among Frail Elderly
NCT02351349
The Effects of Frailty on Chronic Kidney Disease
NCT02775305
Impact on Mortality of Screening for Kidney Disease Associated With a Specialized Intervention During Hospitalization in a Territorial Hospital Trust
NCT05033652
Frailty, Cognitive Function and Health-related Quality of Life in Older Adults With Advanced Chronic Kidney Disease.
NCT05705011
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Frailty Fried Phenotype and
* FRAIL scale
Sociodemographics and clinical variables will be collected and serum samples will be obtained in order to implement further studies regarding biomarkers of frailty..
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Difficulty in understanding Spanish or English
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Parc de Salut Mar
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
M José Pérez Sáez
Principal Investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018/7798/I
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.